Home Newsfeeds Occidental CEO Says Most Excess Cash Flow Next Year Will Be Allocated To Buybacks

Occidental CEO Says Most Excess Cash Flow Next Year Will Be Allocated To Buybacks

-Reuters

byBenzinga Newsdesk

November 9, 2022

1 minute read

-Reuters

Syros Pharmaceuticals To Present Initial Data From SELECT-AML-1 Phase 2 Trial At 64th ASH Annual Meeting

By Benzinga Newsdesk

November 3, 9:22 AM

Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced that it will present initial data from the safety lead-in portion of its ongoing

SYRS

Carnival, Micron And 3 Stocks To Watch Heading Into Friday

By Lisa Levin

September 30, 4:11 AM

With US stock futures trading higher this morning on Friday, some of the stocks that may grab investor focus today are as follows:

CCL

Roche’s Approved Lung Cancer Drug Beats Chemo In Rare Type Of Lung Cancer

By Vandana Singh

September 1, 8:15 AM

Roche Holdings AG (OTC: RHHBY) announced that the Phase 3 ALINA study evaluating Alecensa (alectinib), compared with platinum-based chemotherapy, met its primary endpoint of disease-free survival (DFS) at a

RHHBF

U.S. Stocks Turn Negative; Dow Drops Over 100 Points

By Lisa Levin

August 1, 2:39 PM

U.S. stocks turned lower toward the end of trading, with the Dow Jones falling more than 100 points on Monday.

BRID

Occidental CEO Says Most Excess Cash Flow Next Year Will Be Allocated To Buybacks

Related Posts

Syros Pharmaceuticals To Present Initial Data From SELECT-AML-1 Phase 2 Trial At 64th ASH Annual Meeting

Carnival, Micron And 3 Stocks To Watch Heading Into Friday

Roche’s Approved Lung Cancer Drug Beats Chemo In Rare Type Of Lung Cancer

U.S. Stocks Turn Negative; Dow Drops Over 100 Points